Cyclomedica
Company Details
Status: Private
Employees: 51-100
Location:
1 The Crescent, Unit 4, Kingsgrove, New South Wales 2208, AU
Type:
sample
sample
Technology:
sample
About: Cyclomedica is a global leader in nuclear medicine and molecular imaging, focusing on innovative diagnostic solutions for respiratory diseases. As a subsidiary of Cyclopharm Limited, the company is known for its flagship product, Technegas®, a lung imaging agent that enables high-resolution ventilation scans for conditions such as pulmonary embolism and COPD. Founded on advancements in radiopharmaceutical technology, Cyclomedica aims to improve patient outcomes through early intervention and enhanced care protocols.
The company has a strong global presence, having expanded into various markets since its inception. It offers additional products like Pertechnegas, a specialized diagnostic application, and Galligas, a PET imaging variant. Cyclomedica also employs 3D SPECT imaging to enhance diagnostic accuracy in nuclear pulmonology. With ongoing research initiatives and a strategic focus on U.S. market expansion, Cyclomedica continues to advance its mission of elevating standards in respiratory disease management.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Cyclomedica | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.